“…The spread of antibiotic-resistant pathogenic microorganisms represents a serious concern of the scientific community; therefore, the development of newer drugs with increased effect against broad strains of bacteria is imperative. Special attention has been paid to chalcones, a class of organic compounds with a broad range of biological activities, including antibacterial, antitumor, antimalarial, anti-inflammatory, and anti-HIV activities [ 1 , 2 , 3 , 4 ]. Moreover, chalcones are versatile precursors in the synthesis of numerous pharmacologically active heterocycle compounds, flavonoids, and isoflavonoids [ 5 , 6 ].…”